These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 23038460)

  • 21. Bacterial flagellin is a dominant antigen in Crohn disease.
    Lodes MJ; Cong Y; Elson CO; Mohamath R; Landers CJ; Targan SR; Fort M; Hershberg RM
    J Clin Invest; 2004 May; 113(9):1296-306. PubMed ID: 15124021
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The gut mucosal immune response to Toxoplasma gondii.
    Cohen SB; Denkers EY
    Parasite Immunol; 2015 Mar; 37(3):108-17. PubMed ID: 25418610
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Host-microbiota interactions in inflammatory bowel disease.
    Elson CO; Cong Y
    Gut Microbes; 2012; 3(4):332-44. PubMed ID: 22572873
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Coinfection with Heligmosomoides polygyrus fails to establish CD8+ T-cell immunity against Toxoplasma gondii.
    Khan IA; Hakak R; Eberle K; Sayles P; Weiss LM; Urban JF
    Infect Immun; 2008 Mar; 76(3):1305-13. PubMed ID: 18195022
    [TBL] [Abstract][Full Text] [Related]  

  • 25. CXCL9 is important for recruiting immune T cells into the brain and inducing an accumulation of the T cells to the areas of tachyzoite proliferation to prevent reactivation of chronic cerebral infection with Toxoplasma gondii.
    Ochiai E; Sa Q; Brogli M; Kudo T; Wang X; Dubey JP; Suzuki Y
    Am J Pathol; 2015 Feb; 185(2):314-24. PubMed ID: 25432064
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cell-mediated immunity to Toxoplasma gondii develops primarily by local Th1 host immune responses in the absence of parasite replication.
    Gigley JP; Fox BA; Bzik DJ
    J Immunol; 2009 Jan; 182(2):1069-78. PubMed ID: 19124750
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Update on mucosal immunoglobulin A in gastrointestinal disease.
    Brandtzaeg P
    Curr Opin Gastroenterol; 2010 Nov; 26(6):554-63. PubMed ID: 20693891
    [TBL] [Abstract][Full Text] [Related]  

  • 28. CD4+ T cell mediated intestinal immunity: chronic inflammation versus immune regulation.
    Westendorf AM; Templin M; Geffers R; Deppenmeier S; Gruber AD; Probst-Kepper M; Hansen W; Liblau RS; Gunzer F; Bruder D; Buer J
    Gut; 2005 Jan; 54(1):60-9. PubMed ID: 15591505
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lamina propria CD4+ T lymphocytes synergize with murine intestinal epithelial cells to enhance proinflammatory response against an intracellular pathogen.
    Mennechet FJ; Kasper LH; Rachinel N; Li W; Vandewalle A; Buzoni-Gatel D
    J Immunol; 2002 Mar; 168(6):2988-96. PubMed ID: 11884471
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Innate lymphoid cells in homeostasis, infection, chronic inflammation and tumors of the gastrointestinal tract.
    Fuchs A; Colonna M
    Curr Opin Gastroenterol; 2013 Nov; 29(6):581-7. PubMed ID: 24100718
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Assessing mucosal immunity with new concepts and innovative, time-honored strategies.
    Erickson KL; Hubbard NE
    Nutr Rev; 2009 Nov; 67 Suppl 2():S172-82. PubMed ID: 19906221
    [TBL] [Abstract][Full Text] [Related]  

  • 32. TLRs in the Gut. III. Immune responses to flagellin in Crohn's disease: good, bad, or irrelevant?
    Gewirtz AT
    Am J Physiol Gastrointest Liver Physiol; 2007 Mar; 292(3):G706-10. PubMed ID: 17038626
    [TBL] [Abstract][Full Text] [Related]  

  • 33. CD4-mediated and CD8-mediated cytotoxic and proliferative immune responses to Toxoplasma gondii in seropositive humans.
    Purner MB; Berens RL; Nash PB; van Linden A; Ross E; Kruse C; Krug EC; Curiel TJ
    Infect Immun; 1996 Oct; 64(10):4330-8. PubMed ID: 8926107
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Impaired innate immunity in mice deficient in interleukin-1 receptor-associated kinase 4 leads to defective type 1 T cell responses, B cell expansion, and enhanced susceptibility to infection with Toxoplasma gondii.
    Béla SR; Dutra MS; Mui E; Montpetit A; Oliveira FS; Oliveira SC; Arantes RM; Antonelli LR; McLeod R; Gazzinelli RT
    Infect Immun; 2012 Dec; 80(12):4298-308. PubMed ID: 23027530
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Immune response and immunopathology during toxoplasmosis.
    Dupont CD; Christian DA; Hunter CA
    Semin Immunopathol; 2012 Nov; 34(6):793-813. PubMed ID: 22955326
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Enteroendocrine Cells: Sensing Gut Microbiota and Regulating Inflammatory Bowel Diseases.
    Yu Y; Yang W; Li Y; Cong Y
    Inflamm Bowel Dis; 2020 Jan; 26(1):11-20. PubMed ID: 31560044
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Fc gamma receptor signaling in mast cells links microbial stimulation to mucosal immune inflammation in the intestine.
    Chen X; Feng BS; Zheng PY; Liao XQ; Chong J; Tang SG; Yang PC
    Am J Pathol; 2008 Dec; 173(6):1647-56. PubMed ID: 18974296
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Vaccination with recombinant adenovirus expressing multi-stage antigens of Toxoplasma gondii by the mucosal route induces higher systemic cellular and local mucosal immune responses than with other vaccination routes.
    Wang T; Yin H; Li Y; Zhao L; Sun X; Cong H
    Parasite; 2017; 24():12. PubMed ID: 28367800
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Apicomplexan infections in the gut.
    Wilhelm CL; Yarovinsky F
    Parasite Immunol; 2014 Sep; 36(9):409-20. PubMed ID: 25201405
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The host selects mucosal and luminal associations of coevolved gut microorganisms: a novel concept.
    Van den Abbeele P; Van de Wiele T; Verstraete W; Possemiers S
    FEMS Microbiol Rev; 2011 Jul; 35(4):681-704. PubMed ID: 21361997
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.